AAAAAA

   
Results: 1-13 |
Results: 13
The immunomodulatory effects of thalidomide on human immunodeficiency virus-infected children
Authors: Hanekom, WA Hughes, J Haslett, PAJ Apolles, P Ganiso, V Allin, R Goddard, E Hussey, GD Kaplan, G
Citation: Wa. Hanekom et al., The immunomodulatory effects of thalidomide on human immunodeficiency virus-infected children, J INFEC DIS, 184(9), 2001, pp. 1192-1196
A pilot study evaluating ceftriaxone and penicillin G as treatment agents for neurosyphilis in human immunodeficiency virus-infected individuals
Authors: Marra, CM Boutin, P McArthur, JC Hurwitz, S Simpson, G Haslett, PAJ van der Horst, C Nevin, T Hook, EW
Citation: Cm. Marra et al., A pilot study evaluating ceftriaxone and penicillin G as treatment agents for neurosyphilis in human immunodeficiency virus-infected individuals, CLIN INF D, 30(3), 2000, pp. 540-544
Propionibacterium acnes as the cause of endocarditis in a liver transplantrecipient
Authors: Moreira, AL Haslett, PAJ Symmans, WF Tierno, PM
Citation: Al. Moreira et al., Propionibacterium acnes as the cause of endocarditis in a liver transplantrecipient, CLIN INF D, 30(1), 2000, pp. 224-226
Thalidomide for the treatment of AIDS-associated wasting
Authors: Kaplan, G Thomas, S Fierer, DS Mulligan, K Haslett, PAJ Fessel, WJ Smith, LG Kook, KA Stirling, D Schambelan, M
Citation: G. Kaplan et al., Thalidomide for the treatment of AIDS-associated wasting, AIDS RES H, 16(14), 2000, pp. 1345-1355
Isolation of cytomegalovirus-specific cytotoxic T-lymphocytes from gut-associated lymphoid tissue (GALT) of HIV type 1-infected subjects
Authors: Shacklett, BL Beadle, TJ Pacheco, PA Grendell, JH Haslett, PAJ King, AS Ogg, GS Basuk, PM Nixon, DF
Citation: Bl. Shacklett et al., Isolation of cytomegalovirus-specific cytotoxic T-lymphocytes from gut-associated lymphoid tissue (GALT) of HIV type 1-infected subjects, AIDS RES H, 16(12), 2000, pp. 1157-1162
Adjunctive thalidomide therapy of childhood tuberculous meningitis: Possible anti-inflammatory role
Authors: Schoeman, JF Springer, P Ravenscroft, A Donald, PR Bekker, LG van Rensburg, AJ Hanekom, WA Haslett, PAJ Kaplan, G
Citation: Jf. Schoeman et al., Adjunctive thalidomide therapy of childhood tuberculous meningitis: Possible anti-inflammatory role, J CHILD NEU, 15(8), 2000, pp. 497-503
Characterization of HIV-1-specific cytotoxic T lymphocytes expressing the mucosal lymphocyte integrin CD103 in rectal and duodenal lymphoid tissue ofHIV-1-infected subjects
Authors: Shacklett, BL Beadle, TJ Pacheco, PA Grendell, JH Haslett, PAJ King, AS Ogg, GS Basuk, PM Nixon, DF
Citation: Bl. Shacklett et al., Characterization of HIV-1-specific cytotoxic T lymphocytes expressing the mucosal lymphocyte integrin CD103 in rectal and duodenal lymphoid tissue ofHIV-1-infected subjects, VIROLOGY, 270(2), 2000, pp. 317-327
Human immunodeficiency virus type 1-and cytomegalovirus-specific cytotoxicT lymphocytes can persist at high frequency for prolonged periods in the absence of circulating peripheral CD4(+) T cells
Authors: Spiegel, HML Ogg, GS DeFalcon, E Sheehy, ME Monard, S Haslett, PAJ Gillespie, G Donahoe, SM Pollack, H Borkowsky, W McMichael, AJ Nixon, DF
Citation: Hml. Spiegel et al., Human immunodeficiency virus type 1-and cytomegalovirus-specific cytotoxicT lymphocytes can persist at high frequency for prolonged periods in the absence of circulating peripheral CD4(+) T cells, J VIROLOGY, 74(2), 2000, pp. 1018-1022
Strong human immunodeficiency virus (HIV)-specific CD4(+) T cell responsesin a cohort of chronically infected patients are associated with interruptions in anti-HIV chemotherapy
Authors: Haslett, PAJ Nixon, DF Shen, Z Larsson, M Cox, WI Manandhar, R Donahoe, SM Kaplan, G
Citation: Paj. Haslett et al., Strong human immunodeficiency virus (HIV)-specific CD4(+) T cell responsesin a cohort of chronically infected patients are associated with interruptions in anti-HIV chemotherapy, J INFEC DIS, 181(4), 2000, pp. 1264-1272
Thalidomide stimulates T cell responses and interleukin 12 production in HIV-infected patients
Authors: Haslett, PAJ Klausner, JD Makonkawkeyoon, S Moreira, A Metatratip, P Boyle, B Kunachiwa, W Maneekarn, N Vongchan, P Corral, LG Elbeik, T Shen, Z Kaplan, G
Citation: Paj. Haslett et al., Thalidomide stimulates T cell responses and interleukin 12 production in HIV-infected patients, AIDS RES H, 15(13), 1999, pp. 1169-1179
Thalidomide in toxic epidermal necrolysis
Authors: Klausner, JD Kaplan, G Haslett, PAJ
Citation: Jd. Klausner et al., Thalidomide in toxic epidermal necrolysis, LANCET, 353(9149), 1999, pp. 324-324
Differential cytokine modulation and T cell activation by two distinct classes of thalidomide analogues that are potent inhibitors of TNF-alpha
Authors: Corral, LG Haslett, PAJ Muller, GW Chen, R Wong, LM Ocampo, CJ Patterson, RT Stirling, DI Kaplan, G
Citation: Lg. Corral et al., Differential cytokine modulation and T cell activation by two distinct classes of thalidomide analogues that are potent inhibitors of TNF-alpha, J IMMUNOL, 163(1), 1999, pp. 380-386
Mycobacterium tuberculosis CDC1551 induces a more vigorous host response in vivo and in vitro, but is not more virulent than other clinical isolates
Authors: Manca, C Tsenova, L Barry, CE Bergtold, A Freeman, S Haslett, PAJ Musser, JM Freedman, VH Kaplan, G
Citation: C. Manca et al., Mycobacterium tuberculosis CDC1551 induces a more vigorous host response in vivo and in vitro, but is not more virulent than other clinical isolates, J IMMUNOL, 162(11), 1999, pp. 6740-6746
Risultati: 1-13 |